Search results for "Place"

showing 10 items of 3222 documents

Pioneer: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis w…

2019

Background: The gain-of function mutation KIT D816V plays a central role in the pathogenesis of systemic mastocytosis (SM). Among subtypes of SM, indolent SM (ISM) is the most frequent and is associated with normal/near-normal life expectancy; smoldering SM (SSM) is a subtype with a relatively higher burden of mast cells and may be associated with an increased risk of progression to advanced mastocytosis. However, both ISM and SSM patients may experience severe symptoms associated with mast cell mediator release, such as pruritus, diarrhea, anaphylaxis, and bone pain, which can be severely debilitating and have a profoundly negative impact on quality of life. Symptomatic treatments (eg, ant…

medicine.medical_specialtybusiness.industrySurrogate endpointImmunologyPhases of clinical researchCell BiologyHematologymedicine.diseasePlaceboBiochemistryDouble blindInternal medicineMedicineIn patientSystemic mastocytosismedicine.symptombusinessBone painAsthmaBlood
researchProduct

Photobiomodulation and myofascial temporomandibular disorder: Systematic review and meta-analysis followed by cost-effectiveness analysis

2021

Background Photobiomodulation (PBM) is a non-invasive and non-pharmacological treatment, which, has shown beneficial results in the treatment of temporomandibular disorders (TMD) related pain. This systematic review and meta-analysis study aimed to evaluate the efficacy of photobiomodulation in the treatment of myofascial pain associated with (TMD by analyzing randomized clinical trials published from 2007 to February 2019. The secondary objective of the study was to perform a cost-effectiveness analysis of TMD treatment with photobiomodulation in patients with myofascial pain. Material and methods International databases were used: Pubmed, Medline and Web of Science; the initial search rai…

medicine.medical_specialtybusiness.industryTemporomandibular disorderMEDLINEOrthodonticsCost-effectiveness analysisReviewPlacebolaw.inventionQuality of evidenceRandomized controlled trialLaser therapylawMeta-analysisPhysical therapyMedicinebusinessGeneral DentistryUNESCO:CIENCIAS MÉDICASJournal of Clinical and Experimental Dentistry
researchProduct

Intraoperative Sonographie bei lumbalen Bandscheibenvorfällen

2008

UNLABELLED Intraoperative ultrasound of the spine has been used in neurosurgery (tumours) and traumatology (reposition of fractured vertebral bodies fragments). AIM To describe initial experiences with this method and to document the opportunities and problems. METHOD 24 nucleotomies were documented and evaluated. Sonography was performed using a 7.5 MHz sector probe and a typical surgical approach. RESULTS In 21 of 24 cases, imaging of intraspinal structures was possible. The complete extraction of the herniated disk could be documented. In 3 cases the examination failed because the probe was too large to be pushed down between the spinous processes and the wound retractor to the operative…

medicine.medical_specialtybusiness.industryTraumatologymedicine.diseaseIntervertebral diskLumbarmedicine.anatomical_structureMedicineRadiology Nuclear Medicine and imagingDisplacement (orthopedic surgery)Spinal canalNeurosurgeryRadiologyDiskectomybusinessHerniated diskUltraschall in der Medizin
researchProduct

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability

2013

Aims Mirabegron, the first β3-adrenoceptor agonist to enter clinical practice, has a different mechanism of action from antimuscarinic agents. This review presents data on the efficacy, safety, and tolerability of mirabegron in studies conducted to date. Methods All clinical data on mirabegron that are currently in the public domain are included, including some in-press manuscripts. Results In Phase III clinical trials in patients with overactive bladder (OAB), mirabegron at daily doses of 25, 50, and 100 mg demonstrated significant efficacy in treating the symptoms of OAB, including micturition frequency, urgency incontinence, and urgency. Significant improvements in micturition frequency,…

medicine.medical_specialtybusiness.industryUrologyPlacebomedicine.diseaseSurgeryDiscontinuationClinical trialOveractive bladderTolerabilityInternal medicinemedicineNeurology (clinical)TolterodineMirabegronbusinessAdverse effectmedicine.drugNeurourology and Urodynamics
researchProduct

Long-term safety, tolerability and efficacy of flexible-dose fesoterodine in elderly patients with overactive bladder: Open-label extension of the SO…

2013

Aims To assess the long-term safety, tolerability, and efficacy of flexible-dose fesoterodine in elderly patients with OAB. Methods Patients aged ≥65 years who completed a 12-week, randomized, double-blind, placebo-controlled trial were eligible for the 12-week, open-label (OL) extension phase. Patients who received double-blind placebo started on fesoterodine 4 mg and could increase to 8 mg after 4 or 8 weeks of OL treatment, while fesoterodine-treated patients continued on their double-blind dose; only one dose escalation or de-escalation was permitted. Discontinuations and adverse events (AEs) were monitored, and patients completed 3-day bladder diaries and patient-reported outcomes at t…

medicine.medical_specialtybusiness.industryUrologyUrinary incontinencePlacebomedicine.diseaseTolerabilityOveractive bladderQuality of lifeLower urinary tract symptomsAnesthesiaInternal medicineFesoterodineMedicineNeurology (clinical)medicine.symptombusinessAdverse effectmedicine.drugNeurourology and Urodynamics
researchProduct

Enzyme replacement therapy for Fabry's disease – Authors' reply

2010

medicine.medical_specialtybusiness.industryUrologymedicineGeneral MedicineEnzyme replacement therapybusinessFabry's diseaseThe Lancet
researchProduct

Venous thromboembolism in patients hospitalized for knee and hip joint replacement surgery

2020

Abstract Background Venous thromboembolism (VTE) is a frequent acute cardiovascular disease, leading to significant morbidity and mortality worldwide. Major trauma, surgery, immobilisation and joint replacements are major provoking factors for VTE. In particular, patients undergoing knee and hip joint replacement surgery are at high risk of developing VTE perioperatively, even in the era of established pharmacological thromboprophylaxis. Without thromboprophylaxis, as many as 20–60% of patients may develop perioperative VTE. Purpose As recent studies indicate an increasing number of total knee and hip replacement surgeries in European countries and the United States, aims of our study were …

medicine.medical_specialtybusiness.industrymedicineIn patientCardiology and Cardiovascular MedicinebusinessVenous thromboembolismHip joint replacementSurgeryEuropean Heart Journal
researchProduct

A double blind placebo-controlled study on the rectal administration of morphine as a premedication in abdominal hysterectomy

2000

Abstract Benzodiazepines are now commonly used as anxiolytic premedication prior to surgery. However, the role of opioids, as a premedication, has diminished over the last decades and they are no longer routinely used for premedication. Rather, opioids are generally used to treat severe pain in the postoperative period. Studies have shown that both NSAIDs and opioids improve analgesia in the early postoperative period. Until now, there have been no studies investigating the effect of morphine as a rectal premedication in adults in combination with blood levels of morphine. The effect of a rectal premedication with 30 mg of morphine sulphate, on postoperative pain levels and opioid consumpti…

medicine.medical_specialtybusiness.industrymedicine.drug_classPlacebo-controlled studySuppositoryAnxiolyticSurgeryAnesthesiology and Pain MedicineOpioidRectal administrationAnesthesiaEmergency MedicinemedicineMorphinePremedicationbusinessIntravenous Patient-Controlled Analgesiamedicine.drugAcute Pain
researchProduct

Nutrition in Pediatric Kidney Disease

2018

AbstractNutrition has a major impact on the health of children with chronic kidney disease (CKD). Special diets and additional replacement therapies may be chosen according to the specific renal disease. Persistent low-grade inflammation, which contributes to CKD-associated cardiovascular and all-cause mortality, protein-energy wasting, oxidative stress, acidosis, chronic and recurrent infections, and altered metabolism of adipose tissue may result from dietary deficits and are important targets for nutritive intervention. Therefore, many guidelines have been developed regarding nutrient intake adequation to assist pediatricians treating these children. Acute kidney injury (AKI) has multifa…

medicine.medical_specialtybusiness.industrymedicine.medical_treatment030232 urology & nephrologyAcute kidney injuryDiseaseurologic and male genital diseasesMicronutrientmedicine.disease03 medical and health sciencesMalnutrition0302 clinical medicine030225 pediatricsPediatrics Perinatology and Child HealthmedicineEtiologySurgeryRenal replacement therapymedicine.symptombusinessIntensive care medicineWastingKidney diseaseJournal of Child Science
researchProduct

Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-ana…

2020

Summary Background The timing of renal replacement therapy (RRT) for severe acute kidney injury is highly debated when no life-threatening complications are present. We assessed whether a strategy of delayed versus early RRT initiation affects 28-day survival in critically ill adults with severe acute kidney injury. Methods In this systematic review and individual patient data meta-analysis, we searched MEDLINE (via PubMed), Embase, and the Cochrane Central Register of Controlled Trials for randomised trials published from April 1, 2008, to Dec 20, 2019, that compared delayed and early RRT initiation strategies in patients with severe acute kidney injury. Trials were eligible for inclusion …

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentAbsolute risk reductionAcute kidney injuryGeneral Medicine030204 cardiovascular system & hematologyurologic and male genital diseasesmedicine.diseaseClinical trial03 medical and health sciences0302 clinical medicineInternal medicineRelative riskMeta-analysisSeverity of illnessmedicine030212 general & internal medicineRenal replacement therapybusinessKidney diseaseThe Lancet
researchProduct